NASDAQ:MDRXAllscripts Healthcare Solutions Competitors & Alternatives

Science Applications International (NYSE:SAIC) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability.

Insider & Institutional Ownership

75.2% of Science Applications International shares are owned by institutional investors. 0.9% of Science Applications International shares are owned by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Science Applications International and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and target prices for Science Applications International and Allscripts Healthcare Solutions, as provided by MarketBeat.

Science Applications International currently has a consensus price target of $100.70, suggesting a potential upside of 46.01%. Allscripts Healthcare Solutions has a consensus price target of $8.50, suggesting a potential upside of 28.98%. Given Science Applications International's stronger consensus rating and higher possible upside, analysts plainly believe Science Applications International is more favorable than Allscripts Healthcare Solutions.

Risk & Volatility

Science Applications International has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Valuation & Earnings

This table compares Science Applications International and Allscripts Healthcare Solutions' revenue, earnings per share and valuation.

Science Applications International has higher revenue and earnings than Allscripts Healthcare Solutions. Science Applications International is trading at a lower price-to-earnings ratio than Allscripts Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Summary

Science Applications International beats Allscripts Healthcare Solutions on 13 of the 14 factors compared between the two stocks.

Parsons (NYSE:PSN) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Insider and Institutional Ownership

99.5% of Parsons shares are owned by institutional investors. 0.2% of Parsons shares are owned by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Parsons and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Risk & Volatility

Parsons has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Parsons and Allscripts Healthcare Solutions, as provided by MarketBeat.com.

Parsons currently has a consensus price target of $41.40, suggesting a potential upside of 25.11%. Allscripts Healthcare Solutions has a consensus price target of $8.50, suggesting a potential upside of 28.98%. Given Allscripts Healthcare Solutions' higher possible upside, analysts plainly believe Allscripts Healthcare Solutions is more favorable than Parsons.

Earnings and Valuation

This table compares Parsons and Allscripts Healthcare Solutions' top-line revenue, earnings per share and valuation.

Parsons has higher revenue and earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Parsons, indicating that it is currently the more affordable of the two stocks.

Summary

Parsons beats Allscripts Healthcare Solutions on 12 of the 14 factors compared between the two stocks.

Verint Systems (NASDAQ:VRNT) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Profitability

This table compares Verint Systems and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Verint Systems and Allscripts Healthcare Solutions' top-line revenue, earnings per share and valuation.

Verint Systems has higher earnings, but lower revenue than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Verint Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

90.9% of Verint Systems shares are owned by institutional investors. 1.7% of Verint Systems shares are owned by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Verint Systems has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Verint Systems and Allscripts Healthcare Solutions, as provided by MarketBeat.com.

Verint Systems currently has a consensus price target of $59.25, suggesting a potential upside of 40.94%. Allscripts Healthcare Solutions has a consensus price target of $8.50, suggesting a potential upside of 28.98%. Given Verint Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Verint Systems is more favorable than Allscripts Healthcare Solutions.

Summary

Verint Systems beats Allscripts Healthcare Solutions on 12 of the 14 factors compared between the two stocks.

Allscripts Healthcare Solutions (NASDAQ:MDRX) and NetScout Systems (NASDAQ:NTCT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Allscripts Healthcare Solutions and NetScout Systems' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Allscripts Healthcare Solutions and NetScout Systems' top-line revenue, earnings per share (EPS) and valuation.

NetScout Systems has lower revenue, but higher earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than NetScout Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

96.2% of NetScout Systems shares are owned by institutional investors. 1.4% of Allscripts Healthcare Solutions shares are owned by company insiders. Comparatively, 4.1% of NetScout Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Allscripts Healthcare Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, NetScout Systems has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Allscripts Healthcare Solutions and NetScout Systems, as provided by MarketBeat.

Allscripts Healthcare Solutions presently has a consensus target price of $8.50, suggesting a potential upside of 28.98%. NetScout Systems has a consensus target price of $25.00, suggesting a potential downside of 1.54%. Given Allscripts Healthcare Solutions' stronger consensus rating and higher probable upside, analysts clearly believe Allscripts Healthcare Solutions is more favorable than NetScout Systems.

Summary

NetScout Systems beats Allscripts Healthcare Solutions on 8 of the 14 factors compared between the two stocks.

Allscripts Healthcare Solutions (NASDAQ:MDRX) and Scientific Games (NASDAQ:SGMS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Allscripts Healthcare Solutions and Scientific Games' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Allscripts Healthcare Solutions and Scientific Games' top-line revenue, earnings per share (EPS) and valuation.

Scientific Games has higher revenue and earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Scientific Games, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

59.6% of Scientific Games shares are owned by institutional investors. 1.4% of Allscripts Healthcare Solutions shares are owned by company insiders. Comparatively, 40.3% of Scientific Games shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Allscripts Healthcare Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Scientific Games has a beta of 2.51, meaning that its stock price is 151% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Allscripts Healthcare Solutions and Scientific Games, as provided by MarketBeat.

Allscripts Healthcare Solutions presently has a consensus target price of $8.50, suggesting a potential upside of 28.98%. Scientific Games has a consensus target price of $31.20, suggesting a potential upside of 90.19%. Given Scientific Games' stronger consensus rating and higher probable upside, analysts clearly believe Scientific Games is more favorable than Allscripts Healthcare Solutions.

Summary

Scientific Games beats Allscripts Healthcare Solutions on 8 of the 14 factors compared between the two stocks.

Onespan (NASDAQ:OSPN) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

68.9% of Onespan shares are held by institutional investors. 18.0% of Onespan shares are held by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Onespan and Allscripts Healthcare Solutions, as provided by MarketBeat.com.

Onespan presently has a consensus target price of $25.00, suggesting a potential downside of 7.99%. Allscripts Healthcare Solutions has a consensus target price of $8.50, suggesting a potential upside of 28.98%. Given Allscripts Healthcare Solutions' higher probable upside, analysts plainly believe Allscripts Healthcare Solutions is more favorable than Onespan.

Profitability

This table compares Onespan and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Onespan and Allscripts Healthcare Solutions' top-line revenue, earnings per share (EPS) and valuation.

Onespan has higher earnings, but lower revenue than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Onespan, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Onespan has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.

Summary

Onespan beats Allscripts Healthcare Solutions on 11 of the 14 factors compared between the two stocks.